SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-251126
Filing Date
2018-08-17
Accepted
2018-08-17 09:02:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d576002ds3a.htm S-3/A 182408
2 EXHIBIT 23.2 d576002dex232.htm EX-23.2 1586
3 GRAPHIC g576002g0725075924972.jpg GRAPHIC 5156
  Complete submission text file 0001193125-18-251126.txt   192435
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3/A | Act: 33 | File No.: 333-226341 | Film No.: 181024816
SIC: 3826 Laboratory Analytical Instruments